+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Hantavirus pulmonary syndrome: clinical, diagnostic, and virologic aspects



Hantavirus pulmonary syndrome: clinical, diagnostic, and virologic aspects



Seminars in Respiratory Infections 10(4): 259-269



Hantavirus pulmonary syndrome is an acute pneumonitis with a high mortality rate that is caused by a newly recognized hantavirus. Four Corners virus (also known as Muerto Canyon virus and Sin Nombre virus) is enzootic among deer mice (Peromyscus maniculatus). Incidental transmission to humans can result in a disease characterized by rapidly progressive respiratory insufficiency, diffuse noncardiogenic pulmonary edema, vascular volume contraction with hemoconcentration, lactic acidosis, depressed cardiac output, and cardiac dysrhythmias preterminally. The onset of pulmonary edema is preceded by a prodrome of fever and severe myalgias. Characteristic laboratory abnormalities include thrombocytopenia, leukocytosis with prevalent immature myeloid cells, and the presence of immunoblastic lymphocytes in the peripheral blood. Agent-specific diagnosis is based on the detection of Four Corners virus-specific antibodies in serum by Western blot assays and the detection of Four Corners virus RNA in peripheral blood mononuclear cells by the reverse transcriptase-polymerase chain reaction. Effective treatment depends on the rapid institution of intensive care support.

(PDF emailed within 1 workday: $29.90)

Accession: 046211913

Download citation: RISBibTeXText

PMID: 8668854


Related references

Hantavirus pulmonary syndrome in Brazil: clinical aspects of three new cases. Revista do Instituto de Medicina Tropical de Sao Paulo 42(1): 41-46, 2000

Twenty years of hantavirus pulmonary syndrome in Brazil: a review of epidemiological and clinical aspects. Journal of Infection in Developing Countries 8(2): 137-142, 2014

Pulmonary and cardiovascular syndrome due to hantavirus: clinical aspects of an emerging disease in southeastern Brazil. Revista Da Sociedade Brasileira de Medicina Tropical 42(3): 282-289, 2009

Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. New England Journal of Medicine 330(14): 949-955, 1994

Time to revise the paradigm of hantavirus syndromes? Hantavirus pulmonary syndrome caused by European hantavirus. European Journal of Clinical Microbiology & Infectious Diseases 30(5): 685-690, 2011

Hantavirus pulmonary syndrome in Brasilia periphery: a diagnostic challenge. Journal of Infection in Developing Countries 3(8): 639-643, 2009

Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annual Review of Medicine 50: 531-545, 1999

Hantavirus pulmonary syndrome, renal insufficiency, and myositis associated with infection by Bayou hantavirus. Clinical Infectious Diseases 23(3): 495-500, 1996

Hantavirus in human and rodent populations in an endemic area for hantavirus pulmonary syndrome in Argentina. Medicina (Buenos Aires) 62(1): 1-8, 2002

RIBA hantavirus strip immunoblot assay for rapid diagnosis of hantavirus pulmonary syndrome. Abstracts of the General Meeting of the American Society for Microbiology 96(0): 292, 1996

Characterization of human antibody responses to four corners hantavirus infections among patients with hantavirus pulmonary syndrome. Journal of Virology 68(5): 3000-3006, 1994

Phylogenetically distinct hantavirus implicated in a case of hantavirus pulmonary syndrome in the northeastern United States. Journal Of Medical Virology. 46(1): 21-27, 1995

A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS). Vaccine 31(40): 4314-4321, 2014